Observational studyBMC ophthalmology2016

Tolerability and efficacy of bimatoprost 0.01 % in patients with open-angle glaucoma or ocular hypertension evaluated in the Taiwanese clinical setting: the Asia Pacific Patterns from Early Access of Lumigan 0.01 % (APPEAL Taiwan) study.

Ying Ying Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.